Gentirigeoside B from <i>Gentiana rigescens</i> Franch Prolongs Yeast Lifespan via Inhibition of TORC1/Sch9/Rim15/Msn Signaling Pathway and Modification of Oxidative Stress and Autophagy

Gentirigeoside B (GTS B) is a dammaren-type triterpenoid glycoside isolated from <i>G. rigescens</i> Franch, a traditional Chinese medicinal plant. In the present study, the evaluation of the anti-aging effect and action mechanism analysis for this compound were conducted. GTS B signific...

Full description

Saved in:
Bibliographic Details
Main Authors: Lan Xiang (Author), Dejene Disasa (Author), Yanan Liu (Author), Rui Fujii (Author), Mengya Yang (Author), Enchan Wu (Author), Akira Matsuura (Author), Jianhua Qi (Author)
Format: Book
Published: MDPI AG, 2022-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c0c30e7ddab547c582a89e664b19a3bb
042 |a dc 
100 1 0 |a Lan Xiang  |e author 
700 1 0 |a Dejene Disasa  |e author 
700 1 0 |a Yanan Liu  |e author 
700 1 0 |a Rui Fujii  |e author 
700 1 0 |a Mengya Yang  |e author 
700 1 0 |a Enchan Wu  |e author 
700 1 0 |a Akira Matsuura  |e author 
700 1 0 |a Jianhua Qi  |e author 
245 0 0 |a Gentirigeoside B from <i>Gentiana rigescens</i> Franch Prolongs Yeast Lifespan via Inhibition of TORC1/Sch9/Rim15/Msn Signaling Pathway and Modification of Oxidative Stress and Autophagy 
260 |b MDPI AG,   |c 2022-11-01T00:00:00Z. 
500 |a 10.3390/antiox11122373 
500 |a 2076-3921 
520 |a Gentirigeoside B (GTS B) is a dammaren-type triterpenoid glycoside isolated from <i>G. rigescens</i> Franch, a traditional Chinese medicinal plant. In the present study, the evaluation of the anti-aging effect and action mechanism analysis for this compound were conducted. GTS B significantly extended the replicative lifespan and chronological lifespan of yeast at doses of 1, 3 and 10 μM. Furthermore, the inhibition of Sch9 and activity increase of Rim15, Msn2 proteins which located downstream of TORC1 signaling pathway were observed after treatment with GTS B. Additionally, autophagy of yeast was increased. In addition, GTS B significantly improved survival rate of yeast under oxidative stress conditions as well as reduced the levels of ROS and MDA. It also increased the gene expression and enzymatic activities of key anti-oxidative enzymes such as Sod1, Sod2, Cat and Gpx. However, this molecule failed to extend the lifespan of yeast mutants such as ∆<i>cat</i>, ∆<i>gpx</i>, ∆<i>sod1</i>, ∆<i>sod2</i>, ∆<i>skn7</i> and ∆<i>uth1</i>. These results suggested that GTS B exerts an anti-aging effect via inhibition of the TORC1/Sch9/Rim15/Msn signaling pathway and enhancement of autophagy. Therefore, GTS B may be a promising candidate molecule to develop leading compounds for the treatment of aging and age-related disorders. 
546 |a EN 
690 |a <i>G. rigescens</i> Franch 
690 |a Gentirigeoside B 
690 |a TORC1 signaling pathway 
690 |a autophagy 
690 |a oxidative stress 
690 |a longevity 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 11, Iss 12, p 2373 (2022) 
787 0 |n https://www.mdpi.com/2076-3921/11/12/2373 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/c0c30e7ddab547c582a89e664b19a3bb  |z Connect to this object online.